Results for tag: "Artificial Vital Organ"

The Artificial Vital Organ (AVO) market is a subset of the biotechnology industry that focuses on the development of artificial organs and tissues to replace or supplement existing organs and tissues. AVOs are designed to mimic the functions of natural organs and tissues, and can be used to treat a variety of medical conditions. AVOs are typically made from synthetic materials, such as polymers, and are often combined with living cells to create a functional organ. AVOs are used in a variety of medical applications, including organ transplantation, tissue engineering, and regenerative medicine. They can also be used to improve the quality of life for patients with chronic diseases, such as diabetes and heart disease. AVOs are also being developed to treat conditions that are not currently treatable with existing medical technologies, such as neurological disorders and cancer. The AVO market is expected to grow significantly in the coming years, as advances in biotechnology and medical technology continue to make AVOs more accessible and affordable. Companies in the AVO market include Organovo, Aspect Biosystems, and Prellis Biologics. Show Less Read more